SLAMF6 and lobular neoplasia: Although it is tempting to propose that the frequency of SLAMF6+ DN T cells could help to identify LN patients requiring aggressive immunosuppressive regimens, such as CYC, it is also important to recognize that our finding could be relevant for only a small group of patients and thus have a limited value in clinical practice.